The effect of triamterene on myocardial phosphodiesterase and adenylate cyclase.
The study concerned the effect of triamterene (TA) and its phase-II metabolite p-hydroxytriamterene-sulphuric acid ester (OH-TA ester) on myocardial phosphodiesterase (PDE) and adenylate cyclase (AC): (1) TA and OH-TA ester exerted a concentration-dependent inhibition of PDE. The estimated IC50 values of 127 and 72 mumol/l were 16 and 9 times higher than that of papaverine with 8 mumol/l. At comparable concentrations, TA produced its inotropic effect (EC50 96 mumol/l) in isolated guinea-pig atria so that PDE inhibition may well account for its pharmacodynamic action. (2) In isolated guinea-pig atria, the cyclic AMP content increased significantly with 15-30 s after the addition of TA and remained increased over a period of 15 min. This increase preceded the positive inotropic action, which reached its maximum after 5-10 min. (3) TA did not affect the basal activity of myocardial AC preparations. AC activation by isoprenaline (30 mumol/l) was, however, strongly inhibited.